Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 06, 2020

SELL
$220.06 - $304.07 $770,210 - $1.06 Million
-3,500 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $758,485 - $1.19 Million
3,500 New
3,500 $827,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ruffer LLP Portfolio

Follow Ruffer LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.